Abstract
In Canada, no patents on embryonic stem cell lines have been granted, though it seems likely that they are technically patentable. Nevertheless, there are reasons to believe that embryonic still cell patents may engender social controversy. Embryonic stem cell research remains a morally contested topic. The granting of patents in the area will serve as another opportunity to engage the debate. In addition, for those who have concerns about the commercialization of research and the commodification of life, stem cell patents will serve as another example of an undesirable trend.
Get full access to this article
View all access options for this article.